Close Menu

NEW YORK – Laboratory Corporation of America said on Tuesday that it will use Thermo Fisher Scientific's Ion Torrent Genexus System and Oncomine Precision Assays for research and development of companion diagnostics as well as for other future oncology and precision medicine applications.

The company said that if the Thermo Fisher system is cleared or approved for diagnostic use, it could also be installed in smaller LabCorp facilities as well as hospitals and at the site of other LabCorp customers to expand access to "efficient, expedient, and cost-effective NGS testing."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.